Start Date
August 31, 2018
Primary Completion Date
December 1, 2020
Study Completion Date
December 1, 2020
Sobetirome (NV1205)
Once a day oral dose of the study drug
Monash Health, Clayton
Hospital Austral, Buenos Aires
Hospital General de ninos Pedro de Elizalde, Buenos Aires
Hospital Clínico San Borja Arriarán, Santiago
Hospital Dr. Luis Calvo Mackenna, Santiago
Fundacion Cardioinfantil, Bogotá
Hôpital Bicêtre - Paris Sud, Paris
Endocrinology Research Center, Moscow
Moscow Morozov's Children Clinical Hospital, Moscow
Saint Petersburg State Pediatric Medical University, Saint Petersburg
National Children's Specialized Hospital 'OKHMATDET', Kiev
Great Ormond Street Hospital for Children, London
Manchester Children's Hospital, Manchester
Lead Sponsor
NeuroVia, Inc.
INDUSTRY